MDWD logo

MediWound Ltd.

MDWD
Healthcare|Biotechnology|IL
$14.25
+0.92 (+6.90%)
Tangible Book / Share
$2.77
Cash / Share
$2.74
Next Earnings Report
Nov 12, 2026
EPS est. -$0.71 · Revenue est. $6.7M
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Nov 5, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (1)

Dec 2026
Est. completion
P3Venous Leg Ulcer (VLU)
A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)
NCT06568627n=216

Recent Press Releases

MediWound Announces Closing of $17.25 Million Bought Deal Offering of Ordinary Shares
Nov 5, 2026 · Globe News Wire
MediWound Announces $15 Million Bought Deal Offering of Ordinary Shares
Nov 3, 2026 · GlobeNewsWire
MediWound to Report Third Quarter 2026 Financial Results
Oct 29, 2026 · GlobeNewsWire
MediWound Awarded Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of NexoBrid®
Sep 22, 2026 · GlobeNewsWire
Independent DSMB Recommends MediWound's EscharEx® Phase III VALUE Study Continue Without Modification
Sep 14, 2026 · GlobeNewsWire
MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 2, 2026 · GlobeNewsWire
MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 13, 2026 · GlobeNewsWire

SEC Filings (51)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 20266-KForeign issuer reportDocumentIndex
Nov 5, 2026424B5Offering prospectusDocumentIndex
Nov 3, 2026FWPDocumentIndex
Nov 3, 2026424B5Offering prospectusDocumentIndex
Aug 28, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 13, 20266-KForeign issuer reportDocumentIndex
May 27, 20266-KForeign issuer reportDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 6, 20266-KForeign issuer reportDocumentIndex
Apr 2, 20266-KForeign issuer reportDocumentIndex
Mar 30, 20266-KForeign issuer reportDocumentIndex
Mar 5, 2026S-8Employee stock planDocumentIndex
Mar 5, 202620-FAnnual report (foreign)DocumentIndex
Mar 5, 20266-KForeign issuer reportDocumentIndex
Feb 19, 20266-KForeign issuer reportDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 11, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 5, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 15, 20266-KForeign issuer reportDocumentIndex
Jan 12, 20266-KForeign issuer reportDocumentIndex
Nov 20, 20256-KForeign issuer reportDocumentIndex
Nov 14, 2025SC 13GPassive 5%+ stakeDocumentIndex
Nov 12, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Oct 3, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Sep 30, 20256-KForeign issuer reportDocumentIndex
Sep 30, 2025424B5Offering prospectusDocumentIndex
Sep 29, 20256-KForeign issuer reportDocumentIndex
Sep 19, 2025SC 13GPassive 5%+ stakeDocumentIndex
Aug 19, 20256-KForeign issuer reportDocumentIndex
Aug 14, 20256-KForeign issuer reportDocumentIndex
Aug 12, 2025SC 13G/APassive 5%+ stakeDocumentIndex
May 21, 20256-KForeign issuer reportDocumentIndex
May 15, 20256-KForeign issuer reportDocumentIndex
May 12, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Apr 7, 20256-KForeign issuer reportDocumentIndex
Mar 28, 2025424B3Offering prospectusDocumentIndex
Mar 27, 2025EFFECTDocumentIndex
Mar 19, 2025F-3Shelf registrationDocumentIndex